Sheik, The written statement you seek certifying that Helen...

Sheik, The written statement you seek certifying that Helen Cameron had absolutely no knowledge of Novo Nordisk's intentions was CBio's ASX announcement on 21 December in response to an ASX query. Point 3 on Page 1 reads: "Correspondence from Novo Nordisk dated 14 December 2011 was addressed and sent to the Acting Managing Director who read the correspondence at approximately 10.35 am Sydney time on Thursday 15 December 2011. This correspondence from Novo Nordisk was the first communication with the Company regarding its decision not to exercise its Option to negotiate a licence for XToll. The Company's Acting Managing Director, who was appointed on 1 December 2011 and who had no previous interaction with Novo Nordisk regarding the Option Agreement, received the letter on behalf of CBio in the first instance." There was no insider trading. End of story. She did not know at the time she decided to sell her shares on Tuesday 13 December.

A trading halt was not necessary on this occasion because the information was confidential to the Board for the 26 hours it took for the Novo Nordisk decision to be put into a statement that was released to the market the next morning, following a full Board meeting including the European directors.

COLINK60, your suggestion that Ms Cameron needed to sell her shares in order to pay for the votes that elected her is as ridiculous as it is defamatory.